This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Biogen, Incorporated, F. Hoffmann-La Roche Ag, Genentech, Inc.. Active years: 2019-2020.
Company Filing History:
2 out of 130 
2 out of 180 
1 out of 3,292 
Years Active: 2019-2020
Title: David Yocum: Innovator in Joint Damage Treatment
Introduction
David Yocum is an accomplished inventor based in San Mateo, CA (US). He has made significant contributions to the field of medical treatments, particularly in methods for addressing joint damage. With a total of 2 patents to his name, Yocum's work is paving the way for advancements in therapeutic approaches.
Latest Patents
Yocum's latest patents focus on innovative methods for treating joint damage. One of his notable inventions involves administering an antagonist that binds to a B-cell surface marker, such as a CD20 antibody. This method is designed to slow the progression of joint damage, as measured by radiography. Additionally, he has developed articles of manufacture that are useful for these treatment methods.
Career Highlights
Throughout his career, David Yocum has worked with prominent companies in the pharmaceutical industry. He has been associated with Biogen, Incorporated and F. Hoffmann-La Roche AG, where he has contributed to various research and development projects aimed at improving patient outcomes.
Collaborations
Yocum has collaborated with several professionals in his field, including Ariella Kelman and Sunil Agarwal. These partnerships have enhanced his research efforts and have been instrumental in the development of his patented methods.
Conclusion
David Yocum's innovative work in treating joint damage showcases his dedication to improving medical treatments. His patents and collaborations reflect a commitment to advancing healthcare solutions.